Category: Legal News
A Delaware jury sides with Johnson & Johnson's DePuy-Synthes subsidiary in a patent spat over 3 spinal implant products, ruling that Globus Medical owes $16 million in damages.
Medtronic successfully fends off 1 of the 3 ongoing German patent infringement battles brought by Edwards Lifesciences over transcatheter aortic valve implantation technology.
California cops stumble on a haul of about 4,500 stolen patient health records during a drug bust in Oakland.
MASSDEVICE ON CALL — An Oakland, Calif., drug bust stumbled on personal health records for about 4,500 Sutter Health patients, hospital administrators warned patients this week.
The records were likely stolen during a massive security breach of Sutter Health security systems in 2011, and the California sheriff department said the find caught them off guard.
The Supreme Court's decision to ban patents on human DNA is an obvious drawback for companies that rely on genes-dependent patents, but the decision is more of a win than a loss for medical device and diagnostics makers, says Jennifer Camacho, partner at international law firm Greenberg Traurig.
The Supreme Court's unanimous decision to ban patents on human genes isn't likely to be popular among companies that have staked their business around a gene-dependent patent, but it's not entirely bad news for medical device maker and diagnostics companies.
The Supreme Court rules unanimously that isolated human genes are not patentable, a major loss for Myriad Genetics and its breast and ovarian cancer risk tests.
The Supreme Court today ruled unanimously that isolated human genes are not patentable, putting in jeopardy patents held by Myriad Genetics for genetic tests that identify genes tied to an increased risk of developing breast cancer and ovarian cancer.
The case hinged on the question of whether an human gene becomes a "human-made invention" once it's targeted and isolated or whether it remains a "product of nature" and thus ineligible for patenting.
A Virginia podiatrist was indicted for lying to a grand jury about her involvement in a scheme to defraud Medicare by collecting reimbursement for procedures using Orthofix's bone growth stimulator.
A federal judge raises the royalty rate NuVasive must pay Medtronic on sales of some of its spinal implants, but not as high as Medtronic wanted.